Ahluwalia Contracts (India) Ltd
NSE:AHLUCONT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
634.2
1 137.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Ahluwalia Contracts (India) Ltd
Ahluwalia Contracts (India) Ltd. engages in the provision of construction related activities. The company is headquartered in New Delhi, Delhi. The firm's project portfolio encompasses projects across hotels, hospitals, commercial and institutional, residential, educational and industrial. The firm's projects include hotel projects, such as Leela Palace Five Star Hotel, Pullman & Novotel Hotel, ITC Gardenia Five Star Hotel and ITC Grand Central Five Star Hotel; hospital projects, such as BPS Mahila Vishwavidyalaya, Tata Medical Centre and Fortis Super Specialties Hospital; commercial and institutional projects, such as Samrat Ashok Convention Kendra, The Republic of Singapore High Commission, Millon Mela Exhibition Complex, IFCI Tower, Cyber Green, Indira Gandhi National Centre and Goa Legislative Assembly Complex; residential projects, such as Lotus Boulevard Group Housing, Pearl Housing and 795 Mass Housing, and industrial projects, such as Ahluminium Smelter Plant, FIAT Automobile Plant and New Holland Tractor Plant.
Ahluwalia Contracts (India) Ltd. engages in the provision of construction related activities. The company is headquartered in New Delhi, Delhi. The firm's project portfolio encompasses projects across hotels, hospitals, commercial and institutional, residential, educational and industrial. The firm's projects include hotel projects, such as Leela Palace Five Star Hotel, Pullman & Novotel Hotel, ITC Gardenia Five Star Hotel and ITC Grand Central Five Star Hotel; hospital projects, such as BPS Mahila Vishwavidyalaya, Tata Medical Centre and Fortis Super Specialties Hospital; commercial and institutional projects, such as Samrat Ashok Convention Kendra, The Republic of Singapore High Commission, Millon Mela Exhibition Complex, IFCI Tower, Cyber Green, Indira Gandhi National Centre and Goa Legislative Assembly Complex; residential projects, such as Lotus Boulevard Group Housing, Pearl Housing and 795 Mass Housing, and industrial projects, such as Ahluminium Smelter Plant, FIAT Automobile Plant and New Holland Tractor Plant.
Strong Revenue & Profit Growth: Q2 FY '26 turnover rose 16.39% YoY to INR 1,177.30 crores, and PAT more than doubled, up 106.07% YoY to INR 79.45 crores.
Margin Expansion: EBITDA margin reached 10.92% and PAT margin improved to 6.63% in Q2, both significantly higher than last year.
Order Book: The company’s order book stands at INR 18,057.60 crores with robust inflows and L1 status in two projects totaling INR 1,620 crores.
Order Inflow Guidance: Management targets FY '26 order inflow of around INR 8,000 crores, confident of meeting the goal.
Revenue & Margin Outlook: The company maintains guidance of 15% to 20% top-line growth and double-digit EBITDA margins for FY '26 and expects similar momentum next year.
Working Capital Improvement: Working capital cycle improved to 87 days from 95 days, with only minor issues in some states.
CapEx Plans: CapEx for FY '26 expected to be below INR 500 crores, around INR 400 crores for FY '27, primarily for machinery and shuttering.